1.
Clin Infect Dis
; 75(1): e920-e923, 2022 Aug 24.
Article
in English
| MEDLINE | ID: covidwho-2008524
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine-induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort.
Subject(s)
COVID-19 , Hematopoietic Stem Cell Transplantation , mRNA Vaccines , COVID-19/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , SARS-CoV-2 , Vaccines , Vaccines, Synthetic , mRNA Vaccines/adverse effects
2.
Blood Adv
; 5(16): 3062-3065, 2021 08 24.
Article
in English
| MEDLINE | ID: covidwho-1398833